title: Somatostatin does not prevent serotonin release and flushing during chemoembolization of carcinoid liver metastases.
authors.affiliation: Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen, Essen, Germany. christian.zimmer@uni-essen.de
authors.forename: Christian
authors.initials: C
authors.lastname: Zimmer
authors.forename: Peter
authors.initials: P
authors.lastname: Kienbaum
authors.forename: Richard
authors.initials: R
authors.lastname: Wiesemes
authors.forename: Jürgen
authors.initials: J
authors.lastname: Peters
mesh_terms: D000758:Anesthesia; D002276:Carcinoid Tumor / Q000556:secondary* / Q000628:therapy*; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects*; D005260:Female; D005483:Flushing / Q000517:prevention & control*; D006439:Hemodynamics / Q000187:drug effects; D006727:Hormone Antagonists / Q000627:therapeutic use*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary* / Q000628:therapy*; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D008875:Middle Aged; D012701:Serotonin / Q000097:blood / Q000378:metabolism*; D013004:Somatostatin / Q000627:therapeutic use*
chemical_list: D006727:Hormone Antagonists; D012701:Serotonin; D013004:Somatostatin